Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 7,141,000 | 6,505,000 | 7,320,000 | 7,500,000 | 7,776,000 |
| Cost of Goods | 1,126,000 | 957,000 | 1,075,000 | 1,129,000 | 864,000 |
| Gross Profit | 6,015,000 | 5,548,000 | 6,245,000 | 6,371,000 | 6,912,000 |
| Operating Expenses | 1,761,000 | 1,781,000 | 2,200,000 | 1,972,000 | 2,374,000 |
| Operating Income | 4,254,000 | 3,767,000 | 4,045,000 | 4,399,000 | 4,538,000 |
| Interest Expense | 269,000 | 261,000 | 265,000 | 242,000 | 227,000 |
| Other Income | 130,000 | 111,000 | 140,000 | 119,000 | 88,000 |
| Pre-tax Income | 4,115,000 | 3,617,000 | 3,920,000 | 4,276,000 | 4,399,000 |
| Income Tax | 1,046,000 | 918,000 | 821,000 | 951,000 | 902,000 |
| Net Income Continuous | 3,069,000 | 2,699,000 | 3,099,000 | 3,325,000 | 3,497,000 |
| Minority Interests | -4,000 | -3,000 | -9,000 | -5,000 | N/A |
| Net Income | $3,073,000 | $2,702,000 | $3,108,000 | $3,330,000 | $3,497,000 |
| EPS Basic Total Ops | 2.35 | 2.07 | 2.36 | 2.52 | 2.62 |
| EPS Basic Continuous Ops | 2.35 | 2.06 | 2.36 | 2.52 | 2.62 |
| EPS Diluted Total Ops | 2.33 | 2.05 | 2.34 | 2.49 | 2.58 |
| EPS Diluted Continuous Ops | 2.33 | 2.04 | 2.34 | 2.48 | 2.58 |
| EBITDA(a) | $4,552,000 | $4,061,000 | $4,337,000 | $4,698,000 | $4,822,000 |